Physicians' Education Resource®, LLC is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Physicians' Education Resource®, LLC designates this live activity for a maximum of 8.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Physicians' Education Resource®, LLC is approved by the California Board of Registered Nursing, Provider #16669 for 8.0 Contact Hours.
Physicians' Education Resource®, LLC is approved by the California Board of Registered Nursing, Provider #16669.
The 3rd Annual Live Medical Crossfire®: Hematologic Malignancies is a live full-day version of the renowned Medical Crossfire® format. This 1-day will allow you to explore many of the most hotly debated clinical issues in the management of hematologic malignancies. This meeting will facilitate the practical application of emerging data key to treating a broad range of these malignancies and provide you with the information you need to confidently make personalized clinical decisions for your patients and apply novel strategies to real-world clinical case scenarios you routinely encounter in your practice.
We have assembled renowned experts in the management of leukemias, lymphomas and myeloma to facilitate discussions among the faculty and the audience. The program format for this meeting is unique. Each tumor’s section will begin with a brief evidence-based assessment of the evolving therapeutic space that will transition quickly to the accompanying clinical questions that will be the focus of the expert crossfire session. Each section will conclude with a crossfire from the live audience. This exciting and innovative format promises to provide you with one of the most highly practical and engaging educational forums in medical education today.
Live Medical Crossfire®: Hematologic Malignancies is a unique opportunity for practitioners who manage hematologic malignancies to both learn from and interact with leading expert national faculty to build upon their clinical knowledge base, apply new data to practice and ultimately improve their practices and patient outcomes.
This educational activity is directed toward medical oncologists. Nurse practitioners, nurses, physician assistants, pharmacists, researchers and other health care professionals interested in the treatment of cancer will be invited to participate.
Upon completion of this activity, participants will be able to:
Anas Younes, MD
Professor of Medicine and Chief of Lymphoma Service
Department of Medicine
Division of Hematologic Oncology
Memorial Sloan Kettering Cancer Center
New York, NY
Hagop M. Kantarjian, MD
Professor and Chairman, Department of Leukemia
Samsung Distinguished University Chair in Cancer Medicine
MD Anderson Cancer Center, University of Texas
Kenneth C. Anderson, MD
Program Director, Jerome Lipper Multiple Myeloma Center and LeBow Institute for Myeloma Therapeutics
Kraft Family Professor of Medicine, Harvard Medical School
Cancer Summaries and Commentaries™: Update from Atlanta – Advances in the Treatment of Multiple Myeloma
Feb 28, 2019
Feb 28, 2019
Feb 28, 2019
23rd Annual International Congress on Hematologic Malignancies®: Focus on Leukemias, Lymphomas, and Myeloma
February 28, 2019 - March 3, 2019